PharmaShots | Incisive News in 3 Shots

Subscribe Now

spondyloarthritis

UCB's Cimzia (certolizumab pegol) Receives the EMA's Approval for a Reduced Maintenance Dose in Patients with Axial Spondyloarthritis Spectrum

UCB's Cimzia (certolizumab pegol) Receives the EMA's Approval for a Reduced Maintenance Dose in Patients with Axial Spondyloarthri...

August 6, 2020

Lilly Reports Results of Taltz (ixekizumab) in P-III COAST-X Study for Non-Radiographic Axial Spondyloarthritis

Lilly Reports Results of Taltz (ixekizumab) in P-III COAST-X Study for Non-Radiographic Axial Spondyloarthritis

April 23, 2019

UCB Partners with MyHealth Teams to boost up Spondyloarthritis social network

UCB Partners with MyHealth Teams to boost up Spondyloarthritis social network

August 8, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us